Demographic variables | Own home | Care home | p value (X 2 test) | Total |
---|---|---|---|---|
No. of patients | 101 | 60 | 161 | |
Age (years): 65-69 | 18 (18%) | 6 (10%) | 0.002 | 24 (15%) |
70-79 | 44 (44%) | 12 (20%) | 56 (35%) | |
80-89 | 31 (31%) | 34 (57%) | 65 (40%) | |
90+ | 8 (8%) | 8 (13%) | 16 (10%) | |
Male gender | 49 (49%) | 25 (42%) | 0.399 | 74 (46%) |
Charlson Index*: 0 | 24 (24%) | 9 (15%) | 0.048 | 33 (20%) |
1-2 | 61 (60%) | 32 (53%) | 93 (58%) | |
3+ | 16 (16%) | 19 (32%) | 35 (22%) | |
Site of infection ** | ||||
LRTI | 29 (29%) | 13 (22%) | 0.199 | 42 (26%) |
SSTI | 20 (20%) | 12 (20%) | 32 (20%) | |
UTI | 24 (24%) | 20 (33%) | 44 (27%) | |
Other | 23 (23%) | 8 (13%) | 31 (19%) | |
Multiple | 5 (5%) | 7 (12%) | 12 (7%) | |
Microbiological isolates | ||||
No. of patients | 22 | 23 | 45 | |
S. aureus | 11 (50%) | 12 (52%) | 0.884 | 23 (51%) |
MRSA | 4 (18%) | 10 (43%) | 0.067 | 14 (31%) |
Gram negative | 10 (45%) | 12 (52%) | 0.652 | 22 (49%) |
Resistant Gram negative *** | 4 (18%) | 8 (35%) | 0.208 | 12 (27%) |
Any resistant organism | 8 (36%) | 16 (70%) | 0.026 | 24 (53%) |
Resistant to initial therapy | 8 (36%) | 13 (57%) | 0.175 | 21 (47%) |